MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgab518

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2021

Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.

van Santen Selveta S, Wolf Peter, Kremenevski Natalia, Boguszewski Cesar L, Beiglböck Hannes, Fiocco Marta, Wijnen Mark, Wallenius Ville R, van den Heuvel-Eibrink Marry M, van der Lely Aart J, Johannsson Gudmundur, Luger Anton, Krebs Michael, Buchfelder Michael, Delhanty Patric J D, Neggers Sebastian J C M M, Olsson Daniel S

СтатьяПеревод пока не подготовлен

Аннотация

CONTEXT: Craniopharyngioma is a sellar tumor associated with high rates of pituitary deficiencies (~ 98%) and hypothalamic obesity (~ 50%).

OBJECTIVE

This work aims to determine the efficacy regarding long-term weight loss after bariatric surgery in obese craniopharyngioma patients with hypothalamic dysfunction.

METHODS

This retrospective, case-control, multicenter, international study included obese craniopharyngioma patients (N = 16; of whom 12 are women) with a history of bariatric surgery (12 Roux-en-Y gastric bypass, 4 sleeve gastrectomy; median age 21 years [range, 15-52 years], median follow-up 5.2 years [range, 2.0-11.3 years]) and age/sex/surgery/body mass index-matched obese controls (N = 155). Weight loss and obesity-related comorbidities up to 5 years after bariatric surgery were compared and changes in hormonal replacement therapy evaluated.

RESULTS

Mean weight loss at 5-year follow-up was 22.0% (95% CI, 16.1%-27.8%) in patients vs 29.5% (95% CI, 28.0%-30.9%) in controls (P = .02), which was less after Roux-en-Y gastric bypass (22.7% [16.9%-28.5%] vs 32.0% [30.4%-33.6%]; P = .003) but at a similar level after sleeve gastrectomy (21.7% [-1.8% to 45.2%] vs 21.8% [18.2%-25.5%]; P = .96). No major changes in endocrine replacement therapy were observed after surgery. One patient died (unknown cause). One patient had long-term absorptive problems.

CONCLUSION

Obese patients with craniopharyngioma had a substantial mean weight loss of 22% at 5-year follow-up after bariatric surgery, independent of type of bariatric surgery procedure. Weight loss was lower than in obese controls after Roux-en-Y gastric bypass. Bariatric surgery appears to be effective and relatively safe in the treatment of obese craniopharyngioma patients.

Для цитирования: van Santen Selveta S, Wolf Peter, Kremenevski Natalia, Boguszewski Cesar L, Beiglböck Hannes, Fiocco Marta, Wijnen Mark, Wallenius Ville R, van den Heuvel-Eibrink Marry M, van der Lely Aart J, Johannsson Gudmundur, Luger Anton, Krebs Michael, Buchfelder Michael, Delhanty Patric J D, Neggers Sebastian J C M M, Olsson Daniel S. Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.. The Journal of clinical endocrinology and metabolism. 2021. DOI: 10.1210/clinem/dgab518.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.